Eledon Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference
IRVINE, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ:ELDN), today announced that David-Alexandre C. Gros, Chief Executive Officer, will participate in a fireside chat at the Ladenburg Thalmann Healthcare Conference on Thursday, September 29, 2022 at 2:00 p.m. ET in New York City.
Related news for (ELDN)
- Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
- Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human
- Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
- eledon pharmaceuticals announces pricing of $85 million underwritten offering of common stock and pre-funded warrants
- eledon pharmaceuticals announces positive initial data from subjects with type 1 diabetes treated with tegoprubart as part of an immunosuppression regimen following islet transplantation in investigator-initiated trial at uchicago medicine